Publication | Open Access
Immunogenicity and Reactogenicity After SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients Taking Belatacept
65
Citations
12
References
2021
Year
Additional measures need to be explored to protect kidney transplant recipients taking belatacept. Best safety practices should be continued despite vaccination among this population.
| Year | Citations | |
|---|---|---|
Page 1
Page 1